[
  {
    "ts": null,
    "headline": "Healthcare’s Momentum Gathers Steam. 3 Stocks With Bullish Charts.",
    "summary": "FEATURE  Healthcare stocks are recovering strongly as the year winds down. The is the best-performing of 11 major S&P sector funds over the past week, month, and three-month periods.  The appeal of this group is its variety.",
    "url": "https://finnhub.io/api/news?id=6542f858d8626283ee7be88254122bfc8d08c3b6bc7a30476bc5a376269d59b3",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763573280,
      "headline": "Healthcare’s Momentum Gathers Steam. 3 Stocks With Bullish Charts.",
      "id": 137548640,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "FEATURE  Healthcare stocks are recovering strongly as the year winds down. The is the best-performing of 11 major S&P sector funds over the past week, month, and three-month periods.  The appeal of this group is its variety.",
      "url": "https://finnhub.io/api/news?id=6542f858d8626283ee7be88254122bfc8d08c3b6bc7a30476bc5a376269d59b3"
    }
  },
  {
    "ts": null,
    "headline": "Liver Failure Market Analysis Report 2025-2035: Gilead Sciences, AbbVie, and Boehringer Ingelheim Lead Advancements in Liver Failure Treatments and Artificial Liver Support Technologies",
    "summary": "Liver failure is a critical condition where the liver loses its ability to detoxify, synthesize proteins, and regulate biochemical processes. It can result from hepatitis, alcohol abuse, NAFLD, autoimmune diseases, or toxins. Key symptoms include jaundice, encephalopathy, ascites, and bleeding. The global liver failure market is expanding due to rising disease prevalence, enhanced healthcare access, and diversified therapies. Innovations in transplantation, artificial liver systems, and pharmaco",
    "url": "https://finnhub.io/api/news?id=ff20ecd1aa862ad2bf1c7fcd7d8cc12d741f0941a6a0dbb2807b48097b31d466",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763560980,
      "headline": "Liver Failure Market Analysis Report 2025-2035: Gilead Sciences, AbbVie, and Boehringer Ingelheim Lead Advancements in Liver Failure Treatments and Artificial Liver Support Technologies",
      "id": 137546411,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "Liver failure is a critical condition where the liver loses its ability to detoxify, synthesize proteins, and regulate biochemical processes. It can result from hepatitis, alcohol abuse, NAFLD, autoimmune diseases, or toxins. Key symptoms include jaundice, encephalopathy, ascites, and bleeding. The global liver failure market is expanding due to rising disease prevalence, enhanced healthcare access, and diversified therapies. Innovations in transplantation, artificial liver systems, and pharmaco",
      "url": "https://finnhub.io/api/news?id=ff20ecd1aa862ad2bf1c7fcd7d8cc12d741f0941a6a0dbb2807b48097b31d466"
    }
  },
  {
    "ts": null,
    "headline": "Portal Hypertension Drugs Market Research Report 2025-2035: Key Dynamics, Pipeline Analysis, Regulatory Landscape, Epidemiology",
    "summary": "The global portal hypertension drugs market is thriving due to rising liver disease rates, particularly cirrhosis and hepatitis, and an aging global population, leading to heightened demand for effective therapies. Key players like Gilead Sciences and Novartis are driving market growth through innovation and strategic partnerships. Despite challenges such as high treatment costs and limited access, ongoing R&D aims to introduce affordable solutions. As awareness of liver health expands, technolo",
    "url": "https://finnhub.io/api/news?id=788a3131bb8361d8fbb59812e7dd72713e48a4940e44e2709d3f091fdc072b7c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763560440,
      "headline": "Portal Hypertension Drugs Market Research Report 2025-2035: Key Dynamics, Pipeline Analysis, Regulatory Landscape, Epidemiology",
      "id": 137546567,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "GILD",
      "source": "Yahoo",
      "summary": "The global portal hypertension drugs market is thriving due to rising liver disease rates, particularly cirrhosis and hepatitis, and an aging global population, leading to heightened demand for effective therapies. Key players like Gilead Sciences and Novartis are driving market growth through innovation and strategic partnerships. Despite challenges such as high treatment costs and limited access, ongoing R&D aims to introduce affordable solutions. As awareness of liver health expands, technolo",
      "url": "https://finnhub.io/api/news?id=788a3131bb8361d8fbb59812e7dd72713e48a4940e44e2709d3f091fdc072b7c"
    }
  },
  {
    "ts": null,
    "headline": "Gilead Sciences, Inc. (GILD) Presents at Jefferies London Healthcare Conference 2025 Transcript",
    "summary": "Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference 2025 November 19, 2025 9:00 AM ESTCompany ParticipantsAndrew Dickinson - Chief Financial...",
    "url": "https://finnhub.io/api/news?id=8baea9ce32ad169fcd392093ada516722ad5db0fa876a997657488b3e1863afa",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1763551407,
      "headline": "Gilead Sciences, Inc. (GILD) Presents at Jefferies London Healthcare Conference 2025 Transcript",
      "id": 137547544,
      "image": "https://static.seekingalpha.com/assets/og_image_1200-29b2bfe1a595477db6826bd2126c63ac2091efb7ec76347a8e7f81ba17e3de6c.png",
      "related": "GILD",
      "source": "SeekingAlpha",
      "summary": "Gilead Sciences, Inc. (GILD) Jefferies London Healthcare Conference 2025 November 19, 2025 9:00 AM ESTCompany ParticipantsAndrew Dickinson - Chief Financial...",
      "url": "https://finnhub.io/api/news?id=8baea9ce32ad169fcd392093ada516722ad5db0fa876a997657488b3e1863afa"
    }
  }
]